Providing an update of the ongoing mpox outbreak and discuss the potential use of vaccines to combat it.
In August 2024, the WHO announced the ongoing mpox outbreak to be a public health emergency of international concern following a surge in cases across Africa and the emergence of a new sexually transmitted strain of the virus. This announcement has been followed by an escalation in measures to prepare for and respond to the ongoing outbreak.
Mpox vaccines offer protection against infection and severe disease. The WHO currently recommends two vaccines against mpox (MVA-BN and LC16) or a third (ACAM2000) when the others are not available.
But with a shortage of doses alongside renewed concerns of ‘vaccine hoarding’, it is unclear what role vaccines will play in the global response to the current outbreak.
In this special Vaccine Centre seminar, we will provide an update of the current mpox outbreak and the potential use of vaccines to combat the spread of the virus.
Topics will include:
- An update on the current outbreak;
- Ongoing mpox research in Nigeria;
- What vaccines are currently available and in what quantities;
- The optimal use of available doses given supply supply constraints.
We invite attendees to join us after the seminar for drinks and networking in the Pumphandle Social.
Speakers
- Professor David Heymann
- Dr Chioma Achi
- Professor Jimmy Whitworth
Event notices
- Please note that you can join this event in person or you can join the session remotely
- Please note that the recording link will be listed on this page when available.
Admission
Contact
